tm
Seeing Is Believing
tm
Seeing Is Believing
BCAX is currently covered by 2 analysts with an average price target of $38.82. This is a potential upside of $20.32 (109.84%) from yesterday's end of day stock price of $18.5.
Bicara Therapeutics Common Stock's activity chart (see below) currently has 5 price targets and 6 ratings on display. The stock rating distribution of BCAX is 100% BUY.
Highest price target for BCAX is $40, Lowest price target is $30, average price target is $35.
Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 13-Jan-2026. First documented stock forecast 06-Dec-2024.
Currently out of the existing stock ratings of BCAX, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Feb-2025
$30
$13.22 (78.78%)
$31
1 months 21 days ago
(13-Jan-2026)
0/3 (0%)
$12.47 (71.14%)
Buy Since 06-Dec-2024
$40
$23.22 (138.38%)
$45
6 months 12 days ago
(22-Aug-2025)
0/3 (0%)
$28.16 (237.84%)
What is BCAX (Bicara Therapeutics Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on BCAX (Bicara Therapeutics Common Stock) with a proven track record?
Which analyst has the current lower performing score on BCAX (Bicara Therapeutics Common Stock) with a proven track record?
Which analyst has the most public recommendations on BCAX (Bicara Therapeutics Common Stock)?
Which analyst is the currently most bullish on BCAX (Bicara Therapeutics Common Stock)?
Which analyst is the currently most reserved on BCAX (Bicara Therapeutics Common Stock)?
